17alpha-ethynylestradiol multiple interactions ISO RGD:1314301 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLXDC2 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:1314300 6480464 Estradiol results in decreased expression of PLXDC2 mRNA CTD PMID:21185374 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLXDC2 mRNA CTD PMID:32741896 17beta-estradiol increases expression ISO RGD:1314301 6480464 Estradiol results in increased expression of PLXDC2 mRNA CTD PMID:19484750 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLXDC2 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1314301 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLXDC2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLXDC2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1314301 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLXDC2 mRNA CTD PMID:19933214 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-hydroxypropanoic acid decreases expression ISO RGD:1314300 6480464 Lactic Acid results in decreased expression of PLXDC2 mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1314301 6480464 tetrabromobisphenol A results in decreased expression of PLXDC2 mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of PLXDC2 mRNA CTD PMID:30071829 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of PLXDC2 mRNA, alpha-Chlorohydrin results in increased expression of PLXDC2 protein CTD PMID:28522335 , PMID:34915118 4,4'-sulfonyldiphenol increases expression ISO RGD:1314301 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PLXDC2 mRNA CTD PMID:30951980 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of PLXDC2 mRNA CTD PMID:24780913 acrylamide decreases expression ISO RGD:1314301 6480464 Acrylamide results in decreased expression of PLXDC2 mRNA CTD PMID:29261810 aflatoxin B1 decreases methylation ISO RGD:1314300 6480464 Aflatoxin B1 results in decreased methylation of PLXDC2 gene CTD PMID:27153756 Aflatoxin B2 alpha decreases methylation ISO RGD:1314300 6480464 aflatoxin B2 results in decreased methylation of PLXDC2 intron CTD PMID:30157460 aristolochic acid decreases expression ISO RGD:1314300 6480464 aristolochic acid I results in decreased expression of PLXDC2 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1314300 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PLXDC2 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1314300 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PLXDC2 mRNA CTD PMID:32525701 arsenite(3-) decreases expression ISO RGD:1314300 6480464 arsenite results in decreased expression of PLXDC2 mRNA CTD PMID:23974009 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of PLXDC2 gene CTD PMID:28931070 azoxystrobin decreases expression ISO RGD:1314300 6480464 azoxystrobin results in decreased expression of PLXDC2 mRNA CTD PMID:33512557 benzo[a]pyrene decreases expression ISO RGD:1314300 6480464 Benzo(a)pyrene results in decreased expression of PLXDC2 mRNA CTD PMID:20064835 bisphenol A increases expression ISO RGD:1314300 6480464 bisphenol A results in increased expression of PLXDC2 mRNA CTD PMID:19371625 bisphenol A affects methylation ISO RGD:1314300 6480464 bisphenol A affects the methylation of PLXDC2 gene CTD PMID:31601247 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of PLXDC2 mRNA CTD PMID:31129395 bisphenol A increases expression ISO RGD:1314301 6480464 bisphenol A results in increased expression of PLXDC2 mRNA CTD PMID:30951980 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PLXDC2 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PLXDC2 mRNA CTD PMID:25181051 more ... bisphenol F increases expression ISO RGD:1314301 6480464 bisphenol F results in increased expression of PLXDC2 mRNA CTD PMID:30951980 cadmium atom multiple interactions ISO RGD:1314301 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of PLXDC2 mRNA CTD PMID:31904401 cadmium dichloride multiple interactions ISO RGD:1314301 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of PLXDC2 mRNA CTD PMID:31904401 calcitriol decreases expression ISO RGD:1314300 6480464 Calcitriol results in decreased expression of PLXDC2 mRNA CTD PMID:26485663 carbon nanotube decreases expression ISO RGD:1314301 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 chlordecone increases expression ISO RGD:1314301 6480464 Chlordecone results in increased expression of PLXDC2 mRNA CTD PMID:33711761 choline multiple interactions ISO RGD:1314301 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLXDC2 mRNA CTD PMID:20938992 cyclosporin A decreases expression ISO RGD:1314300 6480464 Cyclosporine results in decreased expression of PLXDC2 mRNA CTD PMID:20106945 , PMID:27989131 DDT decreases expression EXP 6480464 DDT results in decreased expression of PLXDC2 mRNA CTD PMID:30207508 dexamethasone decreases expression ISO RGD:1314300 6480464 Dexamethasone results in decreased expression of PLXDC2 mRNA CTD PMID:25047013 diethylstilbestrol increases expression ISO RGD:1314300 6480464 Diethylstilbestrol results in increased expression of PLXDC2 mRNA CTD PMID:19371625 dioxygen multiple interactions ISO RGD:1314301 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLXDC2 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1314300 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1314300 6480464 Doxorubicin results in decreased expression of PLXDC2 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PLXDC2 mRNA CTD PMID:29391264 ethanol increases expression ISO RGD:1314301 6480464 Ethanol results in increased expression of PLXDC2 mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:1314301 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLXDC2 mRNA CTD PMID:20938992 fonofos increases methylation ISO RGD:1314300 6480464 Fonofos results in increased methylation of PLXDC2 promoter CTD PMID:22847954 furan increases expression EXP 6480464 furan results in increased expression of PLXDC2 mRNA CTD PMID:27387713 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of PLXDC2 mRNA CTD PMID:33387578 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of PLXDC2 mRNA CTD PMID:21396975 L-methionine multiple interactions ISO RGD:1314301 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLXDC2 mRNA CTD PMID:20938992 lead(0) affects expression ISO RGD:1314300 6480464 Lead affects the expression of PLXDC2 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1314300 6480464 Lead affects the expression of PLXDC2 mRNA CTD PMID:28903495 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of PLXDC2 gene CTD PMID:19589859 methylmercury chloride decreases expression ISO RGD:1314301 6480464 methylmercuric chloride results in decreased expression of PLXDC2 mRNA CTD PMID:29261810 mifepristone increases expression ISO RGD:1314300 6480464 Mifepristone results in increased expression of PLXDC2 mRNA CTD PMID:17584828 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PLXDC2 mRNA CTD PMID:25729387 paracetamol increases expression ISO RGD:1314300 6480464 Acetaminophen results in increased expression of PLXDC2 mRNA CTD PMID:26690555 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PLXDC2 mRNA CTD PMID:33387578 parathion increases methylation ISO RGD:1314300 6480464 Parathion results in increased methylation of PLXDC2 promoter CTD PMID:22847954 phenobarbital affects expression ISO RGD:1314300 6480464 Phenobarbital affects the expression of PLXDC2 mRNA CTD PMID:19159669 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1314301 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of PLXDC2 mRNA CTD PMID:31904401 picoxystrobin decreases expression ISO RGD:1314300 6480464 picoxystrobin results in decreased expression of PLXDC2 mRNA CTD PMID:33512557 pyrogallol increases expression ISO RGD:1314301 6480464 Pyrogallol results in increased expression of PLXDC2 mRNA CTD PMID:20362636 rac-lactic acid decreases expression ISO RGD:1314300 6480464 Lactic Acid results in decreased expression of PLXDC2 mRNA CTD PMID:30851411 resveratrol increases expression ISO RGD:1314300 6480464 resveratrol results in increased expression of PLXDC2 mRNA CTD PMID:19371625 resveratrol increases phosphorylation ISO RGD:1314300 6480464 resveratrol results in increased phosphorylation of PLXDC2 protein CTD PMID:25311616 rotenone decreases expression ISO RGD:1314300 6480464 Rotenone results in decreased expression of PLXDC2 mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO RGD:1314300 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1314300 6480464 Silicon Dioxide analog results in increased expression of PLXDC2 mRNA CTD PMID:23806026 sodium arsenate multiple interactions ISO RGD:1314300 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PLXDC2 mRNA CTD PMID:32525701 Soman decreases expression EXP 6480464 Soman results in decreased expression of PLXDC2 mRNA CTD PMID:19281266 sulforaphane increases expression ISO RGD:1314300 6480464 sulforaphane results in increased expression of PLXDC2 mRNA CTD PMID:26833863 terbufos increases methylation ISO RGD:1314300 6480464 terbufos results in increased methylation of PLXDC2 promoter CTD PMID:22847954 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLXDC2 mRNA CTD PMID:32741896 tetrachloromethane affects expression ISO RGD:1314301 6480464 Carbon Tetrachloride affects the expression of PLXDC2 mRNA CTD PMID:17484886 titanium dioxide decreases expression ISO RGD:1314301 6480464 titanium dioxide results in decreased expression of PLXDC2 mRNA CTD PMID:27760801 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PLXDC2 mRNA CTD PMID:25729387 tributylstannane multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of PLXDC2 mRNA CTD PMID:31129395 trichostatin A decreases expression ISO RGD:1314300 6480464 trichostatin A results in decreased expression of PLXDC2 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1314300 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLXDC2 mRNA CTD PMID:27188386 valproic acid decreases methylation ISO RGD:1314300 6480464 Valproic Acid results in decreased methylation of PLXDC2 gene CTD PMID:29154799 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of PLXDC2 mRNA CTD PMID:29427782 valproic acid multiple interactions ISO RGD:1314300 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLXDC2 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1314300 6480464 Valproic Acid results in decreased expression of PLXDC2 mRNA CTD PMID:26272509 more ... vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of PLXDC2 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of PLXDC2 mRNA CTD PMID:23034163 , PMID:23555832 zearalenone increases expression ISO RGD:1314300 6480464 Zearalenone results in increased expression of PLXDC2 mRNA CTD PMID:19371625